AGEN vs TECH · P/E 1.6, rev $103.5M vs P/E 65, rev $1.22B
Agenus Inc (AGEN) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AGEN revenue for 2024-12-31 was $103.5M. Net income was -$232.3M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AGEN and TECH stock pages for the full models.
Not investment advice.